摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 5-(prop-2-ynyloxy)pyrazine-2-carboxylate | 1432511-53-9

中文名称
——
中文别名
——
英文名称
methyl 5-(prop-2-ynyloxy)pyrazine-2-carboxylate
英文别名
Methyl 5-prop-2-ynoxypyrazine-2-carboxylate;methyl 5-prop-2-ynoxypyrazine-2-carboxylate
methyl 5-(prop-2-ynyloxy)pyrazine-2-carboxylate化学式
CAS
1432511-53-9
化学式
C9H8N2O3
mdl
——
分子量
192.174
InChiKey
RLNRAHFLIVPWPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    61.3
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 5-(prop-2-ynyloxy)pyrazine-2-carboxylate锂硼氢 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以81.5%的产率得到5-(prop-2-yn-1-yloxy)pyrazine-2-carboxylic acid
    参考文献:
    名称:
    β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
    摘要:
    An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pK(a) and thereby dramatically change the pharmacological profile of this class of BACE1 inhibitors. The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF A beta 40 and 42 in rats at oral doses as low as 1 mg/kg. The effect was long lasting, showing a significant reduction of A beta 40 and 42 even after 24 h. In contrast to 89, compound 1b lacking the CF3 group was virtually inactive in vivo.
    DOI:
    10.1021/jm400225m
  • 作为产物:
    描述:
    2-丙炔-1-醇5-氯吡嗪-2-羧酸甲酯potassium tert-butylate 作用下, 以 1,4-二氧六环 为溶剂, 反应 3.0h, 以32%的产率得到methyl 5-(prop-2-ynyloxy)pyrazine-2-carboxylate
    参考文献:
    名称:
    β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
    摘要:
    An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pK(a) and thereby dramatically change the pharmacological profile of this class of BACE1 inhibitors. The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF A beta 40 and 42 in rats at oral doses as low as 1 mg/kg. The effect was long lasting, showing a significant reduction of A beta 40 and 42 even after 24 h. In contrast to 89, compound 1b lacking the CF3 group was virtually inactive in vivo.
    DOI:
    10.1021/jm400225m
点击查看最新优质反应信息